Difference between revisions of "Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5 (Q9833)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 27074349, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2016
| ||||||||||||||
| Property / Publication Date: 2016 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Revision as of 19:48, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zanotti S, et al. Endocr. Rev. (2016) cited as Ref 570 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zanotti S
0 references
Canalis E
0 references
2016
0 references
